Tilray Brands, Inc.
Tilray Brands, Inc. is a U.S.-based consumer products company built around cannabis, beverage alcohol, wellness foods, and related branded products. Its portfolio includes Canadian and international cannabis brands, U.S. craft beer and spirits brands, and hemp-based food products, with operations across North America, Europe, Australia, and Latin America.
Fiscal year 2026 · change from previous year
Development 2021–2026
Business
Share of revenueAdult-use and medical cannabis flower, pre-rolls, vapes, edibles, capsules, and beverages.
Craft beer, seltzers, ciders, non-alcoholic beverages, and spirits sold under multiple brands.
Hemp-based food and nutrition products sold primarily through the Manitoba Harvest brand.
Brand-related activities, distribution, brewpubs, and other ancillary revenue streams.
Customers
Tilray sells to adult-use cannabis consumers, medical patients, beverage distributors, retailers, restaurants, bars, and food shoppers. Its customer base spans regulated cannabis channels in Canada and international medical markets, plus U.S. beverage alcohol channels that include off-premises retail and on-premises hospitality. The company also serves patients and governments through medical cannabis supply agreements and distributors in overseas markets.
Buy branded cannabis products for recreational use, with brand, potency, and price positioning driving choice.
Buy standardized THC and CBD products for prescribed or physician-guided use, valuing quality and supply reliability.
Buy craft beverages through retail and hospitality channels, often choosing local or premium brands.
Purchase beverage and cannabis products for resale, prioritizing brand pull, assortment, and supply continuity.
Buy hemp-based nutrition products for everyday food and wellness use, often through grocery and natural channels.
Strategy
Tilray’s strategy is to build a house of brands across cannabis, beverage, and wellness, using scale and distribution to broaden its consumer reach. It emphasizes product innovation, category management, and entry into new geographies while also managing costs and integrating acquired brands and facilities. The company’s portfolio approach is meant to reduce dependence on any single category and create cross-category brand strength.
Brand strength and product differentiation support shelf space, loyalty, and repeat purchases.
New SKUs and formats help defend share and reach new consumer occasions.
Integration and channel focus are needed to capture synergies and improve route-to-market efficiency.
Export markets diversify revenue and leverage EU-GMP capabilities.
Geography
Q1/2026Tilray is headquartered in Leamington and New York and operates across Canada, the United States, Europe, Australia, and Latin America. Canada is central to its cannabis business, while the U.S. is important for beverage alcohol and hemp foods; Europe and Australia are tied mainly to medical cannabis supply and regulatory approvals. Its geographic mix creates exposure to different regulatory regimes, distribution systems, and consumer preferences.
Share of the revenue the company reports by geography.
Risks
Tilray faces regulatory and licensing risk because cannabis remains tightly controlled across jurisdictions and export/import permissions can delay growth. It also faces integration risk from acquisitions, intense competition in cannabis and beverage alcohol, and asset impairment risk if acquired brands or intangibles underperform. The company’s multi-country footprint adds exposure to changing rules, distribution constraints, and local market preferences.
- Goodwill and intangible asset impairmentImpact: HighLikelihood: High
Acquired brands and businesses may not sustain expected cash flows or valuations.
Exposure: Craft beer and branded consumer assets
- Cannabis regulatory and licensing dependenceImpact: HighLikelihood: Medium
Sales, production, and exports depend on approvals, renewals, and compliance across jurisdictions.
Exposure - Acquisition integration riskImpact: HighLikelihood: Medium
Recent craft beer acquisitions must be integrated into operations, distribution, and brand strategy.
Exposure: Beverage segment
- Competition from legal and illicit cannabisImpact: MediumLikelihood: Medium
Price, product mix, and shelf space are contested in both adult-use and medical channels.
Exposure: Canada and international cannabis markets
- Distribution and facility concentrationImpact: MediumLikelihood: Medium
Production sites, distributors, and route-to-market relationships are essential to service levels.
Exposure: U.S. beverage operations and cannabis production
Accounting
Judgemental itemsProduct sales and advisory/service revenue are recognized when control transfers, affecting period timing.
Impact: Can shift reported revenue between quarters
Cannabis and beverage inventories require estimates for obsolescence, yield, and realizable value.
Impact: Can affect gross margin and write-downs
Acquired brands and businesses must be tested if performance weakens or assumptions change.
Impact: Can create large non-cash charges
Acquisitions create fair value step-ups and amortization that affect reported operating results.
Impact: Impacts COGS, amortization, and adjusted gross profit
These estimates depend on valuation assumptions and future taxable income expectations.
Impact: Can materially affect earnings and tax expense
Similar listed companies
Publicly listed companies with a comparable business focus.
Target Group Inc.
CBDY · Medicinal Chemicals & Botanical Products
Tilly's, Inc
TLYS · Retail-Apparel & Accessory Stores
Glass House Brands Inc.
GLAS · Medicinal Chemicals & Botanical Products
TILT Holdings Inc.
TLLTF · Cigarettes
Trulieve Cannabis Corp.
TRLV · Medicinal Chemicals & Botanical Products
Ayr Wellness Inc.
AYRWF · Medicinal Chemicals & Botanical Products
Last updated: 24/09/2026